Condition: Injury Prevention in Sports · Adherence · Sponsor: Linkoeping University
This is a type 3 hybrid cluster randomised controlled trial, where implementation of the intervention is the primary outcome and preventive effectiveness is the secondary outcome. The overall purpose of this study is to evaluate the added value of implementation support on the use and preventive effectiveness of the injury prevention exercise programme Knee Control+ in male and female, youth and adult amateur football teams. Research questions 1. Does use and injury preventive effect of Knee Control+ differ between teams randomised to an intervention group receiving additional support for Knee Control+ use and teams randomised to a control group with standard access to digital Knee Control+ programme material? 2. Does coach self-efficacy to use Knee Control+, player motivation and player training dosage differ between the intervention and control groups? 3. What are the mediators and moderators that influence use of Knee Control+? 4. How well do the intervention and control groups adhere to Knee Control+ recommended use and is there an association between adherence and preventive efficacy? 5. How are different components of the support material used by the intervention group teams, and how is the implementation support perceived by administrators, coaches and players in the clubs (end-users) and by fitness coaches who educate coaches about the programme (intervention deliverers)? 6. How do coaches perceive their engagement to lead Knee Control+ training with their players …
This description comes directly from the study's public registry record.
Martin Hägglund, Professor · +4613-281388 · martin.hagglund@liu.se
Hanna Lindblom, PhD · +4613284784 · hanna.lindblom@liu.se
Always discuss trial participation with your own doctor first.
| Linköping university | Linköping, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06748443